HealthDay Reports: In Small Study, Rheumatoid Arthritis Drug Appears to Help COVID-19 Patients
The drug, called anakinra, may help with the "cytokine storm" some people with severe COVID-19 have been experiencing.
In Small Study, Rheumatoid Arthritis Drug Appears to Help COVID-19 Patients
THURSDAY, May 7, 2020 (HealthDay News) -- In the scramble to find medicines that beat back COVID-19, researchers from Italy report encouraging results from a small study on a rheumatoid arthritis drug already in use.
The drug, anakinra, may help quiet the runaway immune response known as a "cytokine storm," which imperils some patients with severe COVID-19.
"Until a vaccine is available, we urgently need to find a way to help people survive the most severe symptoms of COVID-19, and to do that without overwhelming the intensive care capacity of hospitals," explained study author Dr. Lorenzo Dagna in a news release from The Lancet Rheumatology. His team published the findings in the journal on May 7.